Jefferies Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Sell
12,600
-12,300
-49% -$1.42M 0.01% 752
2025
Q4
$2.62M Hold
24,900
0.01% 696
2025
Q3
$2.09M Hold
24,900
0.01% 628
2025
Q2
$1.97M Sell
24,900
-22,400
-47% -$1.78M 0.02% 534
2025
Q1
$4.25M Sell
47,300
-58,800
-55% -$5.49M 0.04% 340
2024
Q4
$10.6M Buy
106,100
+49,000
+86% +$5.05M 0.06% 215
2024
Q3
$6.48M Buy
+57,100
New +$6.78M 0.05% 258
2024
Q1
Sell
-72,500
Closed -$7.9M 1868
2023
Q4
$7.9M Buy
72,500
+42,500
+142% +$4.41M 0.05% 276
2023
Q3
$3.09M Hold
30,000
0.03% 477
2023
Q2
$3.46M Buy
+30,000
New +$3.41M 0.03% 481
2023
Q1
Sell
-85,000
Closed -$9.43M 1853
2022
Q4
$9.43M Buy
+85,000
New +$8.69M 0.07% 225

Other funds holding MRK

Jefferies Financial Group's MRK Position: Q1 2026 in Review

Jefferies Financial Group reduced its Merck (MRK) stake by 28% in Q1 2026, selling an estimated $16.1M and leaving 361,688 shares worth $43.5M. The position accounts for 0.3% of the portfolio, ranked #53.

Jefferies Financial Group first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $52.7M in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jefferies Financial Group held 361,688 shares of Merck worth $43.5M as of Q1 2026.
  • Jefferies Financial Group sold 139,240 Merck shares in Q1 2026, an estimated $16.1M.
  • Merck made up 0.3% of Jefferies Financial Group's portfolio in Q1 2026, its #53 holding.
  • Jefferies Financial Group first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Merck position peaked at $52.7M in Q4 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.